🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The scope of GALILEO project (Genomic ALteratIons and cLonal EvOlution in A...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2021-07-12
Trial ID
NCT06234579
Treatments Being Tested
The purpose of this study is to see if using Patient Derived Organoids (PDO...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-04-07
Trial ID
NCT06813079
This study aims to explore for the first time how the different ALK TKIs ha...
Status
Completed
Location
Pfizer Innovations AB
Start Date
2020-12-14
Trial ID
NCT04647110
Treatments Being Tested
The primary purpose of this study is to determine the differences in PFS fo...
Status
Completed
Location
EmpiraMed, Inc.
Start Date
2018-07-23
Trial ID
NCT03546894
Treatments Being Tested
The main aim of this study is to compare the amount of brigatinib in the bl...
Status
Completed
Location
Celerion, Inc.
Start Date
2023-12-20
Trial ID
NCT06132867
Treatments Being Tested
This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studie...
Status
Terminated
Location
CTCA at Western Regional Medical Center
Start Date
2019-07-25
Trial ID
NCT03737994
Treatments Being Tested
This is an open-label, non-randomised, phase II, exploratory, multi-country...
Status
Active Not Recruiting
Location
Complejo Hospitalario de A Coruña
Start Date
2020-05-04
Trial ID
NCT04223596
Treatments Being Tested
The main aim of this study is to learn about the time between the start and...
Status
Active Not Recruiting
Location
Department of Oncology, Shanghai pulmonary hospital
Start Date
2024-01-17
Trial ID
NCT05721950
Treatments Being Tested
Phase Ib clinical trial using autologous dendritric cell (DC) vaccine loade...
Status
Active Not Recruiting
Location
CHUV Oncology Department
Start Date
2022-03-22
Trial ID
NCT05195619
This is a prospective, randomized, open-label, multicenter phase II study i...
Status
Completed
Location
HELIOS Klinikum Emil von Behring
Start Date
2020-03-30
Trial ID
NCT04318938
Treatments Being Tested